Search results
Results from the WOW.Com Content Network
Endo Pharmaceuticals at various times was a significant funder of the American Pain Foundation, which has been accused of producing misleading and biased materials relating to opiod prescribing. [ 52 ] [ 53 ] APF shut down in 2012 after the United States Senate Committee on Finance began an investigation into the relationships between narcotic ...
Endo Pharmaceuticals (ENDP) agreed to buy generics company Qualitest Pharmaceuticals for $1.2 billion cash. Qualitest is the sixth-largest U.S. generics company as measured by prescriptions filled.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
This page was last edited on 5 September 2024, at 13:29 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees.
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs , primarily for skin diseases , gastrointestinal disorders , eye health ...
Prasco is a pharmaceutical company headquartered in Cincinnati, Ohio, and founded in 2002 by E. Thomas Arington, former Chairman and CEO of Duramed Pharmaceuticals and former president of the healthcare consulting firm MarketMaster. The company remains privately held.
Founded in 1919 as a maker of digitalis drugs, [3] Upsher-Smith has traditionally focused on the manufacture of generic medications.. In 2017, after owning it for 47 years, the Evenstad family decided to sell most of the firm, the generics business, to Sawai Group Holdings Co., Ltd. [], a large publicly traded generics company in Japan that had been seeking entry into the U.S. market. [4]